IVERIC bio, Inc.
ISEEDelisted Jul 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001410939
IVERIC bio, Inc. was delisted on Jul 11, 2023; its insiders filed their last Form 4 on Jul 13, 2023; 256 institutions reported holding it in 13F filings for Q2 2023, worth $5.33B in total; Soros Fund Management was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by IVERIC bio, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for IVERIC bio, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sblendorio Glenn | Chief Executive Officer | 0 | Jul 13, 2023 | 0 |
| Graves Adrienne L | Director | 0 | Jul 13, 2023 | 0 |
| Henderson Jane | Director | 0 | Jul 13, 2023 | 0 |
| Roberts Calvin W. | Director | 0 | Jul 13, 2023 | 0 |
| Bolte Axel | Director | 0 | Jul 13, 2023 | 0 |
| Blumenkranz Mark S. | Director | 0 | Jul 13, 2023 | 0 |
| Westby Keith | SVP, Chief Operating Officer | 0 | Jul 13, 2023 | 0 |
| Dugel Pravin | President | 0 | Jul 13, 2023 | 0 |
| Carroll David Francis | SVP, Chief Financial Officer | 0 | Jul 13, 2023 | 0 |
| Gibney Anthony S | EVP, Chief Business Officer | 0 | Jul 13, 2023 | 0 |
| Simms Christopher Paul | SVP, Chief Commercial Officer | 0 | Jul 13, 2023 | 0 |
| Miller Christine Ann | Director | 0 | Jul 13, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2023 (view filing) | Jun 2 | 4 days | Westby KeithSVP, Chief Operating Officer | SSale | −20.0K | $37.87 | −$757.4K | −33.5%39.7K after | 10b5-1 |
| Jul 6, 2023 (view filing) | Jul 3 | 3 days | Westby KeithSVP, Chief Operating Officer | SSale | −20.0K | $39.45 | −$789.0K | −33.5%39.7K after | 10b5-1 |